Experience with long-term treatment with albumin-supplemented botulinum toxin type A

Journal of Neural Transmission

Volumn 116, Issue 4, 2009, Pages 437-441

  Mohammadi, Bahram ^a,b   Kollewe, Katja ^a   Wegener, Maresa ^a   Bigalke, Hans ^a   Dengler, Reinhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Blepharospasm; Botulinum toxin type A; Cervical dystonia; Hemifacial spasm; Low dose therapy

Indexed keywords

ALBUMIN; BOTULINUM TOXIN A; NEUTRALIZING ANTIBODY;

ADULT; AGED; ANAMNESIS; ARTICLE; BLEPHAROSPASM; CERVICAL DYSTONIA; DILUTION; DRUG EFFICACY; FEMALE; HEMIFACIAL SPASM; HUMAN; LATENT PERIOD; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; DRUG THERAPY, COMBINATION; FEMALE; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; TORTICOLLIS; YOUNG ADULT;

EID: 67349216769     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-009-0200-6     Document Type: Article

References (32)

1. K Aoki 1999 Preclinical update on Botox (botulinum toxin type A)-purified neurotoxin complex relative to other botulinum neurotoxin preparations Eur J Neurol 6 Suppl 4 S3 S10 (Pubitemid 30029033)
2. R Bhidayasiri F Cardoso DD Truong 2006 Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations Eur J Neurol 13 Suppl 1 21 29
3. H Bigalke K Wohlfarth A Irmer R Dengler 2001 Botulinum A toxin: Dysport improvement of biological availability Exp Neurol 168 1 162 170 (Pubitemid 32195268)
4. Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005a) Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev (1):CD004900
5. Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005b) Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev (1):CD004899
6. DF D'Costa RJ Abbott 1991 Low dose botulinum toxin in spasmodic torticollis J R Soc Med 84 11 650 651
7. JS Elston 1992 The management of blepharospasm and hemifacial spasm J Neurol 239 1 5 8
8. R Giess M Naumann E Werner R Riemann M Beck I Puls C Reiners KV Toyka 2000 Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 69 1 121 123 (Pubitemid 30410428)
9. H Goschel K Wohlfarth J Frevert R Dengler H Bigalke 1997 Botulinum A toxin therapy: neutralizing and non-neutralizing antibodies-therapeutic consequences Exp Neurol 147 1 96 102 (Pubitemid 27402446)
10. P Greene S Fahn B Diamond 1994 Development of resistance to botulinum toxin type A in patients with torticollis Mov Disord 9 2 213 217 (Pubitemid 24092341)
11. P Haussermann S Marczoch C Klinger M Landgrebe B Conrad A Ceballos-Baumann 2004 Long-term follow-up of cervical dystonia patients treated with botulinum toxin A Mov Disord 19 3 303 308 (Pubitemid 38961084)
12. M Heckmann G Plewig 2005 Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study Arch Dermatol 141 10 1255 1259 (Pubitemid 41498923)
13. J Jankovic 2004 Treatment of cervical dystonia with botulinum toxin Mov Disord 19 Suppl 8 S109 S115 (Pubitemid 38967519)
14. J Jankovic K Schwartz 1995 Response and immunoresistance to botulinum toxin injections Neurology 45 9 1743 1746
15. J Jankovic KD Vuong J Ahsan 2003 Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia Neurology 60 7 1186 1188 (Pubitemid 36418786)
16. S Jitpimolmard S Tiamkao M Laopaiboon 1998 Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases J Neurol Neurosurg Psychiatry 64 6 751 757 (Pubitemid 28274409)
17. WH Jost 2006 Other indications of botulinum toxin therapy Eur J Neurol 13 Suppl 1 65 69
18. KR Kessler M Skutta R Benecke 1999 Long-term treatment of cervical dystonia with botulinum toxin A: efficacy, safety, and antibody frequency. German Dystonia Study Group J Neurol 246 4 265 274 (Pubitemid 29229352)
19. U Laubis-Herrmann K Fries H Topka 2002 Low-dose botulinum toxin-a treatment of cervical dystonia-a double-blind, randomized pilot study Eur Neurol 47 4 214 221 (Pubitemid 34621586)
20. A Marchetti R Magar L Findley JP Larsen Z Pirtosek E Ruzicka R Jech J Slawek F Ahmed 2005 Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study Mov Disord 20 8 937 944 (Pubitemid 41419507)
21. NI Mejia KD Vuong J Jankovic 2005 Long-term botulinum toxin efficacy, safety, and immunogenicity Mov Disord 20 5 592 597 (Pubitemid 40862257)
22. AP Moore LD Blumhardt 1991 A double blind trial of botulinum toxin "A" in torticollis, with one year follow-up J Neurol Neurosurg Psychiatry 54 9 813 816
23. M Naumann 2001 Evidence-based medicine: botulinum toxin in focal hyperhidrosis J Neurol 248 Suppl 1 31 33 (Pubitemid 32285328)
24. W Poewe G Deuschl A Nebe E Feifel J Wissel R Benecke KR Kessler AO Ceballos-Baumann A Ohly W Oertel G Kunig 1998 What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group J Neurol Neurosurg Psychiatry 64 1 13 17 (Pubitemid 28156531)
25. JD Rollnik M Matzke K Wohlfarth R Dengler H Bigalke 2000 Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study Eur Neurol 43 1 9 12 (Pubitemid 30045316)
26. A Suputtitada NC Suwanwela 2005 The lowest effective dose of botulinum A toxin in adult patients with upper limb spasticity Disabil Rehabil 27 4 176 184 (Pubitemid 40468158)
27. A Suputtitada K Phanthumchinda C Locharernkul NC Suwanwela 2004 Hemifacial spasm: results of treatment with low dose botulinum toxin injection J Med Assoc Thai 87 10 1205 1211 (Pubitemid 39486780)
28. D Truong DD Duane J Jankovic C Singer LC Seeberger CL Comella MF Lew RL Rodnitzky FO Danisi JP Sutton PD Charles RA Hauser GL Sheean 2005 Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study Mov Disord 20 7 783 791 (Pubitemid 41227144)
29. P Van den Bergh J Francart S Mourin P Kollmann EC Laterre 1995 Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin Muscle Nerve 18 7 720 729
30. A Viriyavejakul R Vachalathiti N Poungvarin 1998 Botulinum treatment for post-stroke spasticity: low dose regime J Med Assoc Thai 81 6 413 422 (Pubitemid 28500313)
31. K Wohlfarth H Goschel J Frevert R Dengler H Bigalke 1997 Botulinum A toxins: units versus units Naunyn Schmiedebergs Arch Pharmacol 355 3 335 340 (Pubitemid 27117590)
32. YL Yu KY Fong CM Chang 1992 Treatment of idiopathic hemifacial spasm with botulinum toxin Acta Neurol Scand 85 1 55 57